VaramirStart free · no cardSign in
CRMD as of Oct 31 · 17:28 ET
CRMDNasdaqPharmaceutical Preparations

CorMedix Inc. · Brief

Next report

11 days

Nov 11 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
4 of 8≥ implied
avg implied
±15.5%
avg realized
±14.9%
May 6 '25±14.6%▲+23.59%×1.62
Aug 7 '25±17.4%▼−9.54%×0.55
Q3 FY25±16.8%▲+19.45%×1.16
Nov 12 '25±13.2%▲+2.06%×0.16
Jan 8 '26±11.5%▼−32.77%×2.84
Q1 FY26±23.0%▼−11.52%×0.50
May 14 '26±13.7%▲+5.73%×0.42
Q2 FY26±13.6%▲+14.65%×1.08
quarterimplied−35%0+35%realized×
Q2 FY26±13.6%▲+14.65%×1.08
May '26±13.7%▲+5.73%×0.42
Q1 FY26±23.0%▼−11.52%×0.50
Jan '26±11.5%▼−32.77%×2.84
Nov '25±13.2%▲+2.06%×0.16
Q3 FY25±16.8%▲+19.45%×1.16
2 older reports
Aug '25±17.4%▼−9.54%×0.55
May '25±14.6%▲+23.59%×1.62
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

Bull2

194managers reporting a position in the latest quarterly filings13F · Jun 30 '26
+3.06%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

3tracked funds holding CRMDN-PORT · Aug 31 '26
27managers whose positions together make up four fifths of the reported value13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

CRMD report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±13.5% into Nov 11 earnings (Oct 28 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.